The Patent Finder

Egis Gyogyszergyar RT.

Also on record
Records under this name other than the patents Egis Gyogyszergyar RT. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.

Back to Egis Gyogyszergyar RT.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 12,415,792Blarcamesine co-crystals for the manufacture of pharmaceutical dosage form
Held by another company
In force
 · Medium confidence
In forceMedium confidence
US 7,141,604Citalopram for the treatment of elevated blood pressure
Formerly held
Term ended
Term ended Mar 13, 2023 · USPTO record
Term endedTerm ended Mar 13, 2023USPTO record
US 8,778,932Dihydro-Oxazolobenzodiazepinone Compounds, a Process for There Preparation and Pharmaceutical Compositions Containing Them
Lapsed on the fee record
Ended Jul 15, 2022 · High confidence
Lapsed on the fee recordEnded Jul 15, 2022High confidence
US 6,335,469High purity (1R,2S,4R)-(-)-2-[(2′-{N,N-dimethylamino}-ethoxy)]-2-[phenyl]-1,7,7-tri-[methyl]-bicyclo[2.2.1]heptane and pharmaceutically acceptable acid addition salts thereof
Term ended
Term ended May 10, 2020 · USPTO record
Term endedTerm ended May 10, 2020USPTO record
US 6,624,201High Purity (1R,2S,4R)-(−)-2-[(2′-{N,N-DIMETHYLAMINO}-ETHOXY)]-2-[PHENYL]-1,7,7 -Tri-[methyl]-Bicyclo [2.2.1]HEPTANE and Pharmaceutically Acceptable Acid Addition Salts Thereof and a Process for the Preparation of These Compounds as Well as Medicaments Containing 1 or More of These Compounds and Their Use
Term ended
Ended no later than May 10, 2020 · USPTO record
Term endedEnded no later than May 10, 2020USPTO record
US 7,307,168Process for the preparation of 3-{2-′4- (6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyllethyl}-6,7,8,9-tetrahydro-2-methyl-4h-pyrido′1,2-methyl-4h-pyrido′,2-a!pyrimidin-4-one
Lapsed on the fee record
Ended Dec 11, 2019 · USPTO record
Lapsed on the fee recordEnded Dec 11, 2019USPTO record
US 7,189,7112, 3-benzodiazepine derivatives and pharmaceutical compositions containing the same as the active ingredient
Lapsed on the fee record
Ended Mar 13, 2019 · USPTO record
Lapsed on the fee recordEnded Mar 13, 2019USPTO record
US 7,186,848Polymorphs of a 1-pyrrole derivative, intermediate for the preparation of atorvastatin
Lapsed on the fee record
Ended Mar 6, 2019 · USPTO record
Lapsed on the fee recordEnded Mar 6, 2019USPTO record
US 7,098,2102h-pyridazine-3-one derivatives, pharmaceutical compositions containing the same and a process for the preparation of the active ingredient
Lapsed on the fee record
Ended Aug 29, 2018 · USPTO record
Lapsed on the fee recordEnded Aug 29, 2018USPTO record
US 6,908,999Process for the preparation of {2-[4-α-phenyl-p-chlorobenzyl)piperazin-1-yl]ethoxy} acetic acid and novel intermediates therefor
Lapsed on the fee record
Ended Jun 21, 2017 · USPTO record
Lapsed on the fee recordEnded Jun 21, 2017USPTO record
10 of 47 patents shown.
Pro members see all 47.
Pro members: see all 47 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited